These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2220460)

  • 1. Ischemic preconditioning and myocardial stunning: related consequences of brief coronary occlusion and reperfusion?
    Schott RJ; Schaper W
    Adv Cardiol; 1990; 37():32-41. PubMed ID: 2220460
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hibernation, stunning, ischemic preconditioning--new paradigms in coronary disease?].
    Heusch G
    Z Kardiol; 1992 Nov; 81(11):596-609. PubMed ID: 1471397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial effects of brief periods of ischemia followed by reperfusion.
    Jennings RB; Murry C; Reimer KA
    Adv Cardiol; 1990; 37():7-31. PubMed ID: 2220467
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relation between myocardial perfusion, myocardial necrosis and residual glucose metabolism as a vitality parameter in the post-ischemic myocardium following coronary reperfusion].
    Sochor H
    Acta Med Austriaca Suppl; 1989; 39():1-36. PubMed ID: 2787948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The stunned and hibernating myocardium].
    Schanzenbächer P
    Verh Dtsch Ges Inn Med; 1991; 97():91-101. PubMed ID: 1808959
    [No Abstract]   [Full Text] [Related]  

  • 6. Electromechanical characterization of acute experimental myocardial infarction.
    Kornowski R; Hong MK; Shiran A; Fuchs S; Pierre A; Collins SD; Elahham S; Leon MB
    J Invasive Cardiol; 1999 Jun; 11(6):329-36. PubMed ID: 10745543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [-Myocardial protection by preconditioning. Experimental and clinical significance-].
    Strasser R; Vogt A; Schaper W
    Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postischemic mechanical and vascular dysfunction (myocardial "stunning" and microvascular "stunning") and the effects of calcium-channel blockers on ischemia/reperfusion injury.
    Bolli R; Triana F; Jeroudi MO
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III16-25. PubMed ID: 2691139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology of myocardial ischemia].
    Baumgart D; Heusch G
    Klin Anasthesiol Intensivther; 1995; 47():3-45. PubMed ID: 7715178
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion.
    Buxton DB; Mody FV; Krivokapich J; Schelbert HR
    J Mol Cell Cardiol; 1993 Jun; 25(6):667-81. PubMed ID: 8411193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stunned and hibernating myocardium: a brief review.
    Conti CR
    Clin Cardiol; 1991 Sep; 14(9):708-12. PubMed ID: 1742904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiopathological basis of protection of the ischemic myocardium].
    Lerch R; Benzi R
    Schweiz Med Wochenschr; 1990 Oct; 120(42):1523-30. PubMed ID: 2237340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease.
    Cohen MV; Downey JM
    Annu Rev Med; 1996; 47():21-9. PubMed ID: 8712775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The "stunned" and "hibernating myocardium"--diagnosis and clinical implications].
    Erdmann E; Kirsch CM
    Z Kardiol; 1993; 82 Suppl 5():143-7. PubMed ID: 8154155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible myocardial dysfunction in sepsis and ischemia.
    Kan H; Failinger CF; Fang Q; Finkel MS
    Crit Care Med; 2005 Dec; 33(12):2845-7. PubMed ID: 16352971
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
    Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cardioprotective action of quercetin in experimental occlusion and reperfusion of the coronary artery in dogs].
    Kolchin IuN; Maksiutina NP; Balanda PP; Luĭk AI; Bulakh VN; Moĭbenko AA
    Farmakol Toksikol; 1991; 54(6):20-3. PubMed ID: 1804685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myocardial stunning].
    Peuhkurinen K
    Duodecim; 1991; 107(20):1714-6. PubMed ID: 1365940
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
    Skyschally A; Schulz R; Heusch G
    Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic myocardial ischemia--hibernating myocardium: characteristics and limits].
    Heusch G; Schulz R
    Z Kardiol; 1993; 82 Suppl 5():133-41. PubMed ID: 8154154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.